Location History:
- München, DE (2020)
- Munich, DE (2021 - 2024)
Company Filing History:
Years Active: 2020-2024
Title: Boqiao Sun: Innovator in Enzymatic Reactions
Introduction
Boqiao Sun is a notable inventor based in Munich, Germany. He has made significant contributions to the field of enzymatic reactions, particularly in the development of mutants of 7β-hydroxysteroid dehydrogenase. His work has led to advancements in the preparation of ursodeoxycholic acid, a compound with important applications in medicine.
Latest Patents
Boqiao Sun holds a total of 3 patents. His latest patents include innovations related to 7β-hydroxysteroid dehydrogenase mutants and processes for the preparation of ursodeoxycholic acid. The first patent provides a nucleic acid molecule that encodes a 7β-HSDH mutant, which catalyzes the stereospecific enzymatic reduction of a 7-ketosteroid to the corresponding 7-hydroxysteroid. This mutant exhibits decreased substrate inhibition and altered cofactor usage compared to the wildtype enzyme. The second patent focuses on novel 7β-hydroxysteroid dehydrogenase mutants and their use in enzymatic reactions of cholic acid compounds, particularly in synthesizing ursodeoxycholic acid using recombinant microorganisms.
Career Highlights
Boqiao Sun is currently employed at Pharmazell GmbH, where he continues to innovate in the field of biochemistry. His research has been pivotal in enhancing the efficiency of enzymatic processes, which has implications for pharmaceutical development.
Collaborations
He collaborates with esteemed colleagues such as Dirk Weuster-Botz and Michael Braun, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Boqiao Sun's work exemplifies the intersection of innovation and practical application in the field of enzymatic reactions. His contributions are paving the way for advancements in medical compounds, showcasing the importance of research in biochemistry.